Breaking News

Rho Selected by HHS for CRO Network

To facilitate medical countermeasure product development

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Rho’s Federal Systems Division has been selected by the U.S. Department of Health and Human Services (HHS) to be part of a network of five CROs to design and conduct clinical studies for the development of medical countermeasures, including drugs, vaccines and diagnostic tests that help protect public health against bioterrorism, pandemic influenza, and other health emergencies.    The Biomedical Advanced Research and Development Authority (BARDA), part of the HHS Office of the Assistant Secreta...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters